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Minilaparotomy is considered to be a useful treatment alternative to laparoscopic-assisted surgery
from the viewpoint of minimal invasiveness, although it has several limitations for the resection of
malignant tumors. We evaluated the usefulness of distal gastrectomy via minilaparotomy for non-
overweight patients with clinically diagnosed T1N0-1 gastric cancer. Clinicopathological and surgical
data on 30 patients attempted to undergo distal gastrectomy via minilaparotomy (skin incision, 7 cm)
without laparoscopic assistance were analyzed. Inclusion criteria were clinically (preoperatively)
diagnosed T1N0-1 gastric cancer that was not suitable for endoscopic mucosal resection located in the
middle- or lower-third of the stomach and the patient body mass index  25.0 kg/m2. The mini-
laparotomy approach was successful in 27 patients (90%), while laparoscopic assistance was required to
accomplish the procedures in three patients (10%). The type of lymph node dissection was D1 þ a in 23
patients and D1 þ b in 7 patients. The duration of surgery was 105e170 min (median, 143.5 min) and
blood loss was 25e520 mL (median, 152.5 mL). Pathological stage was stage IA in 26 patients, IB in two
patients, and stage II in two patients. Postoperative complications were wound infection in one patient,
bleeding in one patient, and anastomotic ulcer in one patient. The length of postoperative stay was 7
e41 (median, 11) days. With a median follow-up of 31 months, there was no recurrence. Distal
gastrectomy via minilaparotomy seems feasible and safe in the majority of non-overweight patients
with clinically diagnosed T1N0 gastric cancer.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Laparoscopic-assisted distal gastrectomy (LADG) has come to be
widely performed in the treatment of cancer located in the middle-
and lower- third of the stomach. LADG usually requires a small inci-
sion (5e7 cm) for the retrieval of the specimen and performing
anastomosis.1e4 The use of a small incision, as opposed to a full
laparotomy, is believed to be associated with the early recovery of
patients undergoing laparoscopic-assisted colectomy.5 Favorable
outcomes of a minilaparotomy approach without laparoscopic
assistance for the resection of colon cancer have been reported by
several investigators.6e10 In 2003, Onitsuka et al.11 ﬁrst reported their
experienceof distal gastrectomyviaminilaparotomy for the resection
of early gastric cancer. However, little is known about the usefulness
of the minilaparotomy approach, despite some Japanese surgeons
including ourselves meticulously documenting surgical techniques: þ81 49 222 8865.
ida).
ciates Ltd. Published by Elsevier Ltfor performing distal gastrectomy,12,13 pyloric-ring preserving
gastrectomy,14 or total gastrectomy13 via minilaparotomy.
This study was performed to evaluate our initial experience of
distal gastrectomy via minilaparotomy in non-overweight patients
with clinically (preoperatively) diagnosed stage IA (T1N0) or IB
(T1N1) gastric cancer,15 in terms of the feasibility, safety, minimal
invasiveness, and short-term oncological outcome.
2. Methodology
2.1. Deﬁnition of minilaparotomy
We deﬁned a minilaparotomy approach as the distal gastrec-
tomy through a skin incision with a maximum length of 7 cm.
2.2. Patients and indication of minilaparotomy
Between April 2005 and July 2008, curative distal gastrectomy
using a minilaparotomy approach was scheduled for 30 patients
with histologically proven gastric cancer who met the inclusiond. All rights reserved.
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General Surgery, Saitama Medical Center, Saitama Medical
University. The indications for the minilaparotomy approach were
clinically diagnosed T1N0 (stage IA) cancer other than mucosal
cancer that satisﬁed criteria of endoscopic mucosal resection
(differentiated, 2 cm in diameter), or T1N1 (stage IB) cancer,
determined according to the Guidelines of the Treatment of Gastric
Cancer,16 a tumor located in the middle- or lower- third of the
stomach, and patient body mass index  25.0 kg/m2. Informed
consent was obtained from each patient.
The diagnosis of gastric cancer was made by histological
examination of biopsy specimens obtained at endoscopic exami-
nation. The site of lesion and degree of invasion (T-category) were
evaluated comprehensively on the basis of barium examination,
and endoscopic and/or endoscopic ultrasonographic ﬁndings. All
patients underwent abdominal computed tomography to deter-
mine the presence/absence of lymph node metastasis (N-category),
liver metastasis, and distant metastasis.
2.3. Level of lymph node dissection
The type of lymph node dissection (D1þ a or D1þ b) for T1N0-1
cancer was selected in accordance with the Guidelines of the
Treatment of Gastric Cancer.16 Mucosal cancer not satisfying the
criteria for EMRwas treated bymodiﬁed gastrectomy Awith D1þ a
lymph node dissection. Modiﬁed gastrectomy A was also indicated
for differentiated submucosal cancer of less than 1.5 cm in diam-
eter. D1 þ a includes removal of lymph nodes classiﬁed as group 1
lymph nodes (No. 1, 3, 4sb, 4d, 5, and 6) þ No. 7 (along the left
gastric artery) lymph nodes. The submucosal cancer that did not
meet the indications of modiﬁed gastrectomy A was treated by
modiﬁed gastrectomy B with D1 þ b lymph node dissection, whichFig. 1. a: The wound is slid cephalad, caudally, or laterally by the traction utilizing a Kent ret
c: Lymph node dissection around the celiac trunk completed via minilaparotomy. d: The less
hepatic artery and/or celiac trunk.included removal of group 1 lymph nodes, No. 7, No. 8a (along the
common hepatic artery), and No. 9 (around the celiac trunk) lymph
nodes. D1-lymph node dissection included removal of all or part of
the group 1 lymph nodes comprising right paracardial lymph nodes
(No. 1), those along the lesser curvature (No. 3), those along the left
gastroepiploic vessels (No. 4sb), those along the right gastro-
epiploic vessels (No. 4d), the suprapyloric lymph nodes (No. 5), and
the infrapyloric lymph nodes (No. 6), which varied according to the
site of primary tumor. In cases of lower-third cancer, modiﬁed
gastrectomy A included dissection of the No. 8a lymph nodes.
2.4. Surgical procedures
Each patient was placed on the operating table in the supine
position. In principle, all the surgical procedures were performed
utilizing conventional surgical instruments through an upper
median abdominal incision, with a maximum length of 7 cm. The
ﬁrst author (HI) oversaw the procedures as a surpervising assistant.
The median duration of surgical training of operating surgeons
(n ¼ 11) was 7 years (range, 3e16 years). A wound retractor,
Alexis (medium size; Applied Medical, CA, USA) was applied to
the edge of the wound. An assistant slid the wound into position
utilizing conventional retractors. When necessary for dissecting
lymph nodes around the celiac artery, or dissecting the gastro-
splenic ligament, a 6-cm-wide Kent retractor (Takasago, Tokyo,
Japan), whose bar was placed beside the patient’s left-sided axilla,
was used to slide the wound cephalad or laterally (Fig. 1a). This
movable wound allowed direct visualization of almost all the
surgical ﬁeld, enabling lymph node dissection.
The transverse colon and the greater omentum were gently
pulled out of the wound, and the greater omentum was dissected
about 4e5 cm away from the arcade of the gastroepiploic vesselsractor system. b: The omentum dissected 4e5 cm away from the gastroepiploic vessels.
er curvature of the stomach denuded after lymph node dissection around the common
Table 1
Demographic, clinicopathological, and surgical factors.
Median (range)
Age (years) 66.5 (49e86)
Sex (male:female) 18:12
Body mass index (kg/m2) 21.2 (16.6e25.0)
ASA classiﬁcation (I:II:III) 8:12:10
Tumor location (middle-third:lower-third) 12:18
Lymph node dissection (D1 þ a:D1 þ b) 23:7
Number of lymph nodes harvested 23 (12e51)
Pathological stage (IA:IB:II) 26:2:2
Duration of surgery (minutes) 143.5 (105e170)
Blood loss (mL) 152.5 (825e520)
Table 2
Postoperative recovery and analgesic use.
Median (range)
First pass of ﬂatus (days) 1 (1e4)
Start of oral intake (days) 3 (3e5)
Number of analgesic use 1 (0e9)
Postoperative complications 3 (10%)
Postoperative hospital stay (days) 9 (8e42)
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divided where appropriate according to the site of the primary
tumor. The right gastroepiploic artery and vein were ligated and
divided at their roots, and then the right gastric artery was
ligated and divided. The duodenum was divided after the appli-
cation of the purse-string instrument, the anvil head of PCEEA
25 mm (Covidien, Mansﬁeld, MA, USA) or Proximate ILS (SDH25)
(Ethicon Endo-Surgery, Cincinnati, OH, USA) was introduced to
the lumen, and the purse-string suture was tightened. The other
stump of the duodenum was closed by interrupted sutures to
prevent the spillage of gastric juice. With the stomach reﬂected
cranially in the surgical ﬁeld, the lymph nodes and the
surrounding fat tissue along the common hepatic artery were
dissected. Lymph node dissection was progressed along the root
of the splenic artery and celiac axis when necessary (Fig. 1c). The
left gastric artery and vein were each divided at their roots. The
lesser curvature was denuded (Fig. 1d), and the stomach was
transected utilizing a linear stapler, Linear Cutter 100 (Ethicon
Endo-Surgery, Cincinnati, OH, USA) or GIA80 (Covidien, Mans-
ﬁeld, MA, USA). The body of the circular stapler was introduced
into the remnant stomach via the lower cut-end of the stomach.
Stapled anastomosis was performed between the posterior side
of the greater curvature of the remnant stomach and the
duodenum. The site, through which the circular stapler was
introduced, was ﬁnally closed using a linear stapler.
When surgeons experienced difﬁculty in dissecting lymph
nodes around the common hepatic artery and/or celiac trunk, or
the gastrosplenic ligament, or to perform lysis for signiﬁcant
adhesions safely, an ultrasonically activated device, Harmonic
scalpellTM (Ethicon Endo-Surgery, Cincinnati, OH, USA) was used
with the assistance of a laparoscope, which illuminated the deep
surgical ﬁeld through the wound.
2.5. Evaluated factors
The patient age, sex, history of prior abdominal surgery, body
mass index (kg/m2), American Society of Anesthesiologists (ASA)
classiﬁcation, location of tumor, type of lymph node dissection,
pathological stage, number of harvested lymph nodes, duration of
surgery, blood loss, postoperative complications, ﬁrst passage of
ﬂatus, ﬁrst time of oral intake, use of analgesic agents (pentazocine,
15 mg, intramuscularly), and length of postoperative hospital stay
were prospectively recorded on the medical charts and analyzed
retrospectively.
2.6. Statistical analysis
A statistical software package (Statview ver. 5.0; SAS Institute,
Cary, NC, USA) running on aWindows personal computer was used
to conduct the analysis. Continuous data were expressed as median
and range.
3. Results
The extension of minilaparotomy wound was not necessary in
any patients. The length of incision was 6 cm in 14 patients and
7 cm in 16 patients. Theminilaparotomy approachwas successful in
27 patients (90%), while in the remaining three patients (10%)
laparoscopic assistance was needed to perform lymph node
dissection in the deep ﬁeld safely (n¼ 2) or to perform adhesiolysis
(n ¼ 1).
The patient age ranged from 49 to 86 years (median, 66.5 years).
The male:female ratio was 18:12. The patient body mass index
ranged from 16.6 to 25.0 kg/m2 (median, 21.2 kg/m2). The ASA
classiﬁcation was class I in 8 patients, class II in 12 patients, andclass III in 10 patients. Therewere no patients with a history of prior
upper abdominal surgery, although one patient had undergone
anterior resection for rectal cancer. The location of the primary
tumor was the middle-third of the stomach in 12 patients and the
lower-third of the stomach in 18 patients. The type of lymph node
dissection was D1 þ a in 23 patients and D1 þ b in 7 patients.
Duration of surgery ranged from 105 to 170 min (median,
143.5 min) and the blood loss ranged from 25 to 520 mL (median,
152.5 mL). The number of harvested lymph nodes was 12e51
(median, 23). The pathological stage was stage IA in 26 patients,
stage IB in two patients, and stage II in two patients (Table 1).
The duration to ﬁrst ﬂatuswas 1e4 days (median,1 day) and that
to ﬁrst oral intake was 3e5 days (median, 3 days). The number of
times analgesic was used (pentazocine,15mg, intramuscularly)was
0e9 (median, 1). Three patients developed postoperative compli-
cations. One patient each developed wound infection and anasto-
motic ulcer, both of which improved conservatively. The remaining
one patient, inwhom laparoscopic assistancewas needed for lysis of
adhesions between the greater omentum and the parietal perito-
neum, underwent re-operation through theminilaparotomywound
the day after surgery. At re-laparotomy, although hemostasis was
conﬁrmed, the capsule of the spleen was found to have been torn.
The postoperative length of hospital stay ranged from 8 to 42 days
(median, 9 days) (Table 2). There was no recurrence with a median
follow-up period of 31 months (range, 21e60 months).4. Discussion
The underlying concept of the minilaparotomy approach is to
utilize as small an incision as necessary to extract the specimen
right from the beginning of the surgical procedure, enabling divi-
sion of the stomach and the duodenum, lymph node dissection, and
anastomosis under direct viewwithout any laparoscopic assistance.
The deﬁnition of ‘minilaparotomy’ appears to be a matter of
personal opinion. Some Japanese surgeons11,12,14 including
ourselves13 considered the maximal incision length used for distal
gastrectomy via minilaparotomy as 6e7 cm. In addition, Hyodo
et al.17 deﬁned ‘minilaparotomy’ as 5e6 cm through which gasless
laparoscopy-assisted distal gastrectomy was performed using an
abdominal wall lift. Practically, 6e7 cm is the shortest incision that
allows the surgeon to insert his orherhand into theoperativeﬁeld to
provide prompt control for unexpected bleeding. In addition, Rino
et al.18 reported that an incision of 3 cm or longer was needed to
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distal gastrectomy for early gastric cancer. Importantly, surgeons
should note thatmost distal gastrectomieswithD1þ aorD1þ b can
be accomplished through shorter incisions than generally believed.
In 2003, Onitsuka et al.11 ﬁrst reported the experience of mini-
laparotomy (7 cm) in 10 cases of early gastric cancer. They reported
on 5 distal gastrectomies and 5 pyloric-ring preserving gastrecto-
mies, one of which required the extension of the incision to
accomplish the procedures. In their series, themean operation time
was 175 min, although the blood loss was not documented.
Thereafter, some Japanese surgeons12e14 reported their experience
of minilaparotomy approach for the resection of gastric cancer,
focusing on the surgical techniques. To the best of our knowledge,
this is the ﬁrst report documenting minutely the feasibility, safety,
andminimal invasiveness of distal gastrectomy via minilaparotomy
for non-overweight patients with clinically (preoperatively) diag-
nosed stage IA or IB gastric cancer.
In this series, minilaparotomy approach without any laparo-
scopic assistance was not successful in 10% of the patients. Thus, in
some circumstances, minilaparotomy approach may not be
possible. If the surgeon experiences difﬁculty in performing any
procedures via minilaparotomy, he or she should never hesitate to
extend the wound, converting to standard open surgery. Alterna-
tively, as performed in this series, laparoscopic assistance would be
a better choice for enabling dissection of the lymph nodes and/or
vessels more easily and safely. The postoperative bleeding
presumably occurring from the tear of the spleen in one case may
have been avoided if the dissection of vessels near the spleen was
performed carefully with laparoscopic assistance.
Morbid obesity is generally considered to be a relative contra-
indication to LADG. Noshiro et al.1 reported that LADG for early
gastric cancer in patients with BMI > 24.2 kg/m2 resulted in
signiﬁcantly more technical difﬁculties, longer operating time, and
delayed recovery of bowel activity than in those with lower BMI.
For obese patients, even conventional open gastrectomy may be
more difﬁcult to perform than the equivalent procedure in slender
patients. Bearing this and our experience of minilaparotomy
approach to curative colectomy9 in mind, we tentatively excluded
patients with a BMI greater than 25.0 kg/m2, which is the cut-off
value of ‘overweight’.19 Further studies are needed to determine
whether the indication of a minilaparotomy approach could be
expanded to more obese patients.
In institutions where specialized laparoscopic gastric surgeons
are available, LADG has been performed with wider acceptance and
is considered to be the most useful treatment alternative to mini-
mally invasive modalities for early gastric cancer. However, even
now, we are not ready for the wide expansion of LADG to all
institutions. Unlike a laparoscopic-assisted approach, a mini-
laparotomy approach does not have a high cost. In this series, we
used multiple staplers for resection and anastomosis, since the cost
for using multiple staplers is partly (70e90%) reimbursed by the
Japanese health insurance system regardless of the procedures
(laparoscopic-assisted or conventional open). Of course, we
consider that hand-sewn anastomosis would be feasible even in
our minilaparotomy, leading to lower cost than that of this series.
Also, our minilaparotomy approach does not require a long oper-
ating time or highly trained surgeons. There may be arguments
whether one can teach our method to non- experienced surgeons
since the operative view is more limited than the laparoscopic-
assited procedure. As mentioned in our surgical technique, our
“movable wound” technique allowed direct visualization of almost
all the surgical ﬁeld, enabling identiﬁcation and dividing vessels,
and lymph node dissection as in almost similar manner as in
conventional open surgery without taking longer operating time. In
fact, in this series, the median duration of surgical training ofoperating surgeons was 7 years (range, 3e16 years). Considering
the aforementioned issues, we believe that the minilaparotomy
approach to curative distal gastrectomy should continue to be used
as a treatment alternative to LADG depending on surgeon’s pref-
erence and subsequent patients’ selection.
In this series, we could not compare minilaparotomy and
conventional open or laparoscopic-assisted surgery. In the
treatment of colon cancer, a minilaparotomy approach has been
reported to be identical to a laparoscopic approach20 in terms of
minimal invasiveness. In addition, compared with conventional
open surgery, a minilaparotomy approach has been shown to be
less invasive in terms of postoperative recovery and various
laboratory parameters.21,22 The length of our minilaparotomy
(7 cm) is considered not longer than the total length of inci-
sions used for LADG when multiple trocar sites are added to the
main incision length. Since the minilaparotomy is not any longer
than the length performed in LADG, it will certainly be less
painful than a conventional open gastrectomy incision and
comparable to a laparoscopic surgical incision, although such
comparisons were not performed in our series and deserve
further investigations.
In conclusion, this study demonstrated that distal gastrectomy
via minilaparotomy seems feasible, safe, and favorable in early
oncological outcome in the majority of non-overweight patients
with clinically (preoperatively) diagnosed stage IA or IB gastric
cancer. To validate the usefulness of this approach, a prospective
randomized trial comparing this approach with the conventional
open or laparoscopic-assisted procedure, in terms of minimal
invasiveness, cosmetic results, cost, and long-term oncological
outcome, is needed.Conﬂict of interest
None declared.
Funding
None.
Ethical approval
None.References
1. Noshiro H, Shimizu S, Nagai E, Ohuchida K, Tanaka M. Laparoscopy-assisted
distal gastrectomy for early gastric cancer: is it beneﬁcial for patients of heavier
weight? Ann Surg 2003;238:680e5.
2. Kim MC, Kim KH, Kim HH, Jung GJ. Comparison of laparoscopy-assisted by
conventional open distal gastrectomy and extraperigastric lymph node
dissection in early gastric cancer. J Surg Oncol 2005;91:90e4.
3. Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A,
et al. Laparoscopic versus open subtotal gastrectomy for distal gastric
cancer: ﬁve-year results of a randomized prospective trial. Ann Surg
2005;241:232e7.
4. Sakuramoto S, Kikuchi S, Kuroyama S, Futawatari N, Katada N, Kobayashi N,
et al. Laparoscopy-assisted distal gastrectomy for early gastric cancer experi-
ence with 111 consecutive patients. Surg Endosc 2006;20:55e60.
5. Fleshman JW, Fry RD, Birnbaum EH, Kodner IJ. Laparoscopic-assisted and
minilaparotomy approaches to colorectal diseases are similar in early outcome.
Dis Colon Rectum 1996;39:15e22.
6. Fürstenberg S, Goldman S, Machado M, Järhult J. Minilaparotomy approach to
tumors of the right colon. Dis Colon Rectum 1998;41:997e9.
7. Nakagoe T, Sawai T, Tsuji T, Ayabe H. Use of minilaparotomy in the treatment of
colonic cancer. Br J Surg 2001;88:831e6.
8. Takegami K, Kawaguchi Y, Nakayama H, Kubota SY, Nagawa H. Minilaparotomy
approach to colon cancer. Surg Today 2003;33:414e20.
9. Ishida H, Nakada H, Yokoyama M, Hayashi Y, Ohsawa T, Inokuma S, et al.
Minilaparotomy approach for colonic cancer: initial experience of 54 cases.
Surg Endosc 2005;19:316e20.
10. Hsu TC. Feasibility of colectomy with mini-incision. Am J Surg 2005;190:
48e50.
11. Onitsuka A, Katagiri Y, Miyauchi T, Yasunaga H, Mimoto H, Ozeki Y. Min-
ilaparotomy for early gastric cancer. Hepatogastroenterology 2003;50:
883e5.
H. Ishida et al. / International Journal of Surgery 8 (2010) 643e647 64712. Takahashi S, Kojima N, Bandou E, Kawamura Y, Yonemura Y. Distal gastrec-
tomy performed via 6-cm laparotomy for early gastric cancer. Syujyutu
(Operation) 2005;59:1161e5 [in Japanese].
13. Ishiguro T, Sakimoto T, Kubo N, Miyazaki T, Ishibashi K, Ishida H. Mini-
laparotomy (5e7 cm) for gastric cancer. Syujyutsu (Operation) 2008;62:607e12
[in Japanese].
14. Kimura Y, Kubo N, Noguchi T. Useful minilaparotomy approach for pyloric-ring
preserving gastrectomy. Geka-Chiryou (Surgical Treatment) 2008;98:216e9.
15. Japanese Gastric Cancer Association. Japanese classiﬁcation of gastric carci-
noma e 2nd English edition. Gastric Cancer 1998;4:10e24.
16. Japanese Gastric Association. Therapeutic guidelines for gastric cancer. Kane-
hara, Tokyo; 2001 [in Japanese].
17. Hyodo M, Hosoya Y, Yokoyama T, Arai W, Yasuda Y, Nagai H, et al. Gasless
laparoscopy-assisted distal gastrectomy for early cancer via mini-laparotomy
using an abdominal wall lift. Hepatogastroenterology 2003;50:2279e81.
18. Rino Y, Ashida A, Harada H, Kawamoto M, Inagaki D, Yukawa N, et al. Lapa-
roscopy-assisted distal gastrectomy with 3-cm laparotomy, left hepatic lobecompression technique, and selection of automatic anastomosis device. Hep-
atogastroenterology 2007;54:4e9.
19. World Health Organization. Obesity, preventing and managing the global
endemic. WHO Technical Report Series no. 894. WHO; 2000
20. Nakagoe T, Sawai T, Tsuji T, Jibuki M, Nanashima A, Yamaguchi H, et al.
Retrospective comparison of minilaparotomy (“moving window method”) and
laparoscopic-assisted approaches for colon cancer resection. Acta Med Nagasaki
2001;46:25e32.
21. Nakagoe T, Tsuji T, Sawai T, Sugawara K, Inokuchi N, Kamihira S, et al.
Minilaparotomy may be independently associated with reduction in inﬂam-
matory responses after resection for colorectal cancer. Eur Surg Res 2003;35:
477e85.
22. Ishibashi K, Okada N, Nagamine T, Kuwabara K, Ohsawa T, Yokoyama M , et al.
Systemic and peritoneal cytokine response in curative surgery for T2/T3 colon
cancer: comparison of minilaparotomy and conventional laparotomy. J Jpn Coll
Surg 2006;31:801e6. Nihon Gekakei Rengou Gakkai Zassi. [in Japanese with
English abstract].
